Sales 2022 |
418 M
443 M
443 M
|
Net income 2022 |
61,1 M
64,8 M
64,8 M
|
Net Debt 2022 |
107 M
113 M
113 M
|
P/E ratio 2022 |
28,9x |
Yield 2022 |
0,73% |
|
Capitalization |
1 821 M
1 929 M
1 929 M
|
EV / Sales 2022 |
4,61x |
EV / Sales 2023 |
4,03x |
Nbr of Employees |
1 341 |
Free-Float |
30,4% |
|
|
Duration : Auto.2 months3 months6 months9 months1 year2 years5 years10 yearsMax.
Period : DayWeek
|
|
|
Technical analysis trends MEDACTA GROUP SA
|
Short Term |
Mid-Term |
Long Term |
Trends |
Bearish |
Bearish |
Bearish |
Income Statement Evolution
Please enable JavaScript in your browser’s settings to use dynamic charts.
Sell
Buy
|
Mean consensus |
OUTPERFORM |
Number of Analysts |
3 |
Last Close Price |
91,10 € |
Average target price |
124,39 € |
Spread / Average Target |
36,6% |
Please enable JavaScript in your browser’s settings to use dynamic charts.
|
Source: https://www.marketscreener.com/quote/stock/MEDACTA-GROUP-SA-56798268/news/Medacta-Announces-First-Lumbar-Fusion-Procedure-with-NextAR-Augmented-Reality-Surgical-Platform-in-A-40800233/